Compare TOST & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TOST | RVTY |
|---|---|---|
| Founded | 2012 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.0B | 11.6B |
| IPO Year | 2021 | 1994 |
| Metric | TOST | RVTY |
|---|---|---|
| Price | $24.33 | $100.29 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 22 | 16 |
| Target Price | $41.29 | ★ $109.67 |
| AVG Volume (30 Days) | ★ 11.4M | 1.3M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.34% |
| EPS Growth | ★ 1766.67 | N/A |
| EPS | 0.20 | ★ 0.36 |
| Revenue | ★ $6,153,000,000.00 | $3,311,822,000.00 |
| Revenue This Year | $22.69 | $6.37 |
| Revenue Next Year | $18.03 | $5.10 |
| P/E Ratio | ★ $121.50 | $281.36 |
| Revenue Growth | ★ 24.05 | N/A |
| 52 Week Low | $22.26 | $81.22 |
| 52 Week High | $49.66 | $118.30 |
| Indicator | TOST | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 45.21 | 54.03 |
| Support Level | $22.26 | $94.04 |
| Resistance Level | $30.36 | $102.68 |
| Average True Range (ATR) | 0.96 | 3.58 |
| MACD | 0.07 | -0.09 |
| Stochastic Oscillator | 25.22 | 48.50 |
Toast Inc is a cloud-based, all-in-one digital technology platform purpose-built for the restaurant community. The company provides a comprehensive platform of software-as-a-service (SaaS) products and financial technology solutions, including integrated payment processing, restaurant-grade hardware, and a broad ecosystem of third-party partners. It serves as a restaurant operating system, connecting front of house and back of house operations across service models such as dine-in, takeout, and delivery. It operates through one reportable segment consisting of its SaaS products, financial technology solutions, integrated payments, hardware, and partner ecosystem.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.